Tao Shen
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 7
-
- Traditional Chinese Medicine Analysis 10
- Molecular Biology top 5%
- PI3K/AKT/mTOR signaling in cancer 14
- Oncology top 5%
- Cancer-related Molecular Pathways 8
-
- Phytochemistry and Biological Activities 13
-
- Hepatitis B Virus Studies 9
-
- Lung Cancer Treatments and Mutations 9
-
- Hepatitis C virus research 8
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Journal of Biological Chemistry (6 papers)Journal of Clinical Investigation (2 papers)
- Partner nations
- ChinaUnited StatesDenmark
In The Last Decade
Tao Shen
129 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 153
- Cancer Research 595
- Complementary and alternative medicine 227
- Molecular Biology 1.9k
- Oncology 698
- Health, Toxicology and Mutagenesis 261
Countries citing papers authored by Tao Shen
This map shows the geographic impact of Tao Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Shen more than expected).
Fields of papers citing papers by Tao Shen
This network shows the impact of papers produced by Tao Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Shen. The network helps show where Tao Shen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tao Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 11 | |
| 10 | 2022 | 35 | |
| 11 | 2021 | 43 | |
| 12 | 2021 | 23 | |
| 13 | 2020 | 3 | |
| 14 | CeO2NPs relieve radiofrequency radiation, improve testosterone synthesis, and clock gene expression in Leydig cells by enhancing antioxidation | 2019 | 1 |
| 15 | 2019 | 9 | |
| 16 | 2016 | 63 | |
| 17 | 2012 | 64 | |
| 18 | 2011 | 15 | |
| 19 | 2011 | 25 | |
| 20 | 2010 | 84 |
About Tao Shen
Tao Shen is a scholar working on Complementary and alternative medicine, Cancer Research and Hepatology, having authored 141 papers that have together received 3.7k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (14 papers), Phytochemistry and Biological Activities (13 papers), Traditional Chinese Medicine Analysis (10 papers), Hepatitis B Virus Studies (9 papers), Lung Cancer Treatments and Mutations (9 papers), Cancer-related Molecular Pathways (8 papers), Hepatitis C virus research (8 papers) and Cancer, Hypoxia, and Metabolism (7 papers). The work is most often cited by research in Cancer Research (595 citations), Complementary and alternative medicine (227 citations) and Molecular Biology (1.9k citations). Tao Shen has collaborated with scholars based in China, United States and Denmark. Frequent co-authors include Shile Huang, Hongyu Zhou, Wenxing Chen, Baoshan Xu, Xiuzhen Han, Yan Luo, Long Chen, Jie Wu, Yuanzhong Wang and Yan Luo. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.